1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ENANTA PHARMACEUTICALS INC

Enanta Pharmaceuticals Inc

XNAS: ENTA

Weak Stock
Download real time

6.31 -0.13 (-2.02%)

64.55% Fall from 52W High

309.6K XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
8S
17W
0O
3T
66.6

Operating Revenue TTM

Below industry Median
-104.9

Net profit TTM

Negative Net profit TTM
-157.6

Net Profit Margin TTM %

-9.6

Operating Revenue growth TTM %

Negative Operating Revenue growth TTM %
24.1

Net Profit TTM Growth %

Below industry Median
Board Meeting
The next board meeting for Enanta Pharmaceuticals Inc is on 27 Mar 2025 for the purpose of H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference See details

Enanta Pharmaceuticals Inc quarterly, annual results, revenue, profit, P&L, Balance Sheet, Cash Flow, Annual Reports, Margins - 15 Years history